COGT Other | Cogent Biosciences, Inc.

Cogent Biosciences, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2026-02-17: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.001 Par Value · COGT · NASDAQ.
2025-02-25: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.001 Par Value · COGT · NASDAQ.
2024-02-26: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.001 Par Value · COGT · NASDAQ.
2023-11-07: Form 10-Q; Item Smaller reporting company; As filed Yes.

Filed	Form	Item	As filed
2026-02-17	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · COGT · NASDAQ
2025-02-25	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · COGT · NASDAQ
2024-02-26	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · COGT · NASDAQ
2023-11-07	10-Q	Smaller reporting company	Yes
2023-11-07	10-Q	Emerging growth company	Yes
2023-08-08	10-Q	Smaller reporting company	Yes
2023-08-08	10-Q	Emerging growth company	Yes
2023-05-09	10-Q	Smaller reporting company	Yes
2023-05-09	10-Q	Emerging growth company	Yes
2023-03-14	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · COGT · NASDAQ
2023-03-14	10-K	Smaller reporting company	Yes
2023-03-14	10-K	Emerging growth company	Yes
2022-11-14	10-Q	Smaller reporting company	Yes
2022-11-14	10-Q	Emerging growth company	Yes
2022-08-09	10-Q	Smaller reporting company	Yes
2022-08-09	10-Q	Emerging growth company	Yes
2022-05-10	10-Q	Smaller reporting company	Yes
2022-05-10	10-Q	Emerging growth company	Yes
2022-03-15	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · COGT · NASDAQ
2022-03-15	10-K	Smaller reporting company	Yes
2022-03-15	10-K	Emerging growth company	Yes
2022-03-15	10-K	Well-known seasoned issuer	No
2021-11-10	10-Q	Smaller reporting company	Yes
2021-11-10	10-Q	Emerging growth company	Yes
2021-08-16	10-Q	Smaller reporting company	Yes
2021-08-16	10-Q	Emerging growth company	Yes
2021-05-12	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · COGT · NASDAQ
2021-05-12	10-Q	Smaller reporting company	Yes
2021-05-12	10-Q	Emerging growth company	Yes
2021-03-16	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · COGT · NASDAQ
2021-03-16	10-K	Smaller reporting company	Yes
2021-03-16	10-K	Emerging growth company	Yes
2021-03-16	10-K	Well-known seasoned issuer	No
2020-11-09	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · COGT · NASDAQ
2020-11-09	10-Q	Smaller reporting company	Yes
2020-11-09	10-Q	Emerging growth company	Yes
2020-08-11	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · UMRX · NASDAQ
2020-08-11	10-Q	Smaller reporting company	Yes
2020-08-11	10-Q	Emerging growth company	Yes
2020-05-11	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · UMRX · NASDAQ
2020-05-11	10-Q	Smaller reporting company	Yes
2020-05-11	10-Q	Emerging growth company	Yes
2020-03-26	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · UMRX · NASDAQ
2020-03-26	10-K	Smaller reporting company	Yes
2020-03-26	10-K	Emerging growth company	Yes
2020-03-26	10-K	Well-known seasoned issuer	No
2019-11-12	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 Par Value · UMRX · NASDAQ
2019-11-12	10-Q	Smaller reporting company	Yes
2019-11-12	10-Q	Emerging growth company	Yes
2019-08-12	10-Q	Smaller reporting company	Yes
2019-08-12	10-Q	Emerging growth company	Yes
2019-05-13	10-Q	Smaller reporting company	Yes
2019-05-13	10-Q	Emerging growth company	Yes
2019-03-28	10-K	Smaller reporting company	Yes
2019-03-28	10-K	Emerging growth company	Yes
2019-03-28	10-K	Well-known seasoned issuer	No
2018-11-13	10-Q	Emerging growth company	Yes

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Gossamer Bio, Inc. (GOSS)	United States	$5.355B	-0.65
Oruka Therapeutics, Inc. (ORKA)	United States	$5.663B	-43.76
PTC THERAPEUTICS, INC. (PTCT)	United States	$5.199B	-177.07
Travere Therapeutics, Inc. (TVTX)	United States	$5.712B	-123.10
Mirum Pharmaceuticals, Inc. (MIRM)	United States	$5.798B	-8.81
Dianthus Therapeutics, Inc. /DE/ (DNTH)	United States	$5.082B	-27.79
Erasca, Inc. (ERAS)	United States	$5.073B	-19.96
Veradermics, Inc (MANE)	United States	$4.839B
Amneal Pharmaceuticals, Inc. (AMRX)		$6.326B	25.62
Liquidia Corp (LQDA)	United States	$6.347B	51.23